During the past decade, Piedmont Ear, Nose, and Throat Associates conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Piedmont Ear, Nose, and Throat Associates" #1 sponsor was "Aerin Medical" with 5 trials, followed by "Otonomy, Inc." with 3 trials sponsored, "Spirox, Inc." with 2 trials sponsored, "Arrinex, Inc." with 1 trials sponsored and "Astellas Pharma Global Development, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Piedmont Ear, Nose, and Throat Associates" #1 collaborator was "New Arch Consulting" with 1 trials as a collaborator, "Novum Pharmaceutical Research Services" with 1 trials as a collaborator, "Pearl Pathways" with 1 trials as a collaborator and "QST Consultations, Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Piedmont Ear, Nose, and Throat Associates" are "Chronic Rhinitis" (4 trials), "Nasal Obstruction" (3 trials), "Meniere Disease" (2 trials), "Acute Otitis Externa" (1 trials) and "Age-Related Hearing Loss" (1 trials). Many other conditions were trialed in "Piedmont Ear, Nose, and Throat Associates" in a lesser frequency.

Most popular intervention types in "Piedmont Ear, Nose, and Throat Associates" are "Drug" (10 trials), "Device" (9 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Vivaer Stylus" (2 trials), "14-Day Miconazole Oil (Miconazole 2%)" (1 trials), "14-Day Placebo - Oil Vehicle" (1 trials) and "7-Day Miconazole Oil (Miconazole 2%)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Ear, Nose, and Throat Associates" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Piedmont Ear, Nose, and Throat Associates". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Piedmont Ear, Nose, and Throat Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Ear, Nose, and Throat Associates, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".